Biotech · Private company · Harrison, NY, US
SHY Therapeutics
Track this companyFree. Adds SHY Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- SHY-ONC6Phase 1 · Advanced or Metastatic Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid TumorsPHASE1 · RECRUITING · started Jun 24, 2026ClinicalTrials.gov NCT07705334 · fetched Nov 12, 2026
NIH awards2
- Development of a Novel Class of Antifungal TherapyFiscal year 2026 · $286.7KNIH RePORTER 5R43AI186577-02 · fetched Nov 12, 2026
- Development of a Novel Class of Antifungal TherapyFiscal year 2025 · $300.6KNIH RePORTER 1R43AI186577-01A1 · fetched Nov 12, 2026